Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine.
about
Self-assembling protein nanoparticles in the design of vaccinesMalaria vaccine based on self-assembling protein nanoparticlesClassification of self-assembling protein nanoparticle architectures for applications in vaccine designEffectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic miceRecent progress in adjuvant discovery for peptide-based subunit vaccinesSequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases.A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.Optimizing the design of protein nanoparticles as carriers for vaccine applicationsDesign and optimization of peptide nanoparticlesMaterials from peptide assembly: towards the treatment of cancer and transmittable diseasePrinciples Governing the Self-Assembly of Coiled-Coil Protein NanoparticlesMechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.A self-adjuvanting supramolecular vaccine carrying a folded protein antigenThe biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platformsDe novo designed peptides for biological applications.Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.Nanoscale assemblies and their biomedical applications.Applications of nanotechnology for immunology.Functional nanomaterials can optimize the efficacy of vaccines.Vaccine technologies: From whole organisms to rationally designed protein assemblies.α-Helical coiled-coil peptide materials for biomedical applications.Biomaterials Made from Coiled-Coil Peptides.The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine.Self-assembling protein nanoparticles: a promising tool against lethal influenza?A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.Protein nanovaccine confers robust immunity against Toxoplasma.A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virusNanoparticle Vaccines Against Infectious Diseases
P2860
Q26767097-F68F1169-6D22-4DD5-A856-B73D68F10520Q28268609-74F599C3-E8D0-4823-920E-FA3EF3CEC7FDQ33630220-4FD7D37D-F238-41F5-AB6A-CF581C79D605Q33855226-47FB7A9A-9AF6-42CF-A9F4-1191EA0DD41CQ34033780-CF77B33F-6B3B-438F-9ECF-1173B157D112Q34799960-84904690-D257-46B6-86D9-A422E16C0C35Q35927866-0BC4F045-0C9F-4687-9189-A43FE191E569Q36103803-85D603FE-4374-4FBE-8586-E3CCFA63CBA3Q36203154-B22BF961-309F-40D0-A767-5AEC023A7878Q36372698-BF8BC009-6513-40A9-8E3F-408E63A4AB15Q36552606-7570B61E-9E06-4700-8850-C88CCDD89B52Q37151766-C22DCC58-3B27-46E5-BC3A-22B62CD0E38FQ37280623-6B16059A-848A-4990-B091-543EE2B0332EQ37322127-8A0C7262-52FA-4686-8ECD-5361C266BF39Q37849603-6AB35FFD-9B35-441E-8F97-7823B6D8372FQ37921384-1FDD5D14-9272-4316-8294-FC19E18BABBFQ38072847-8B93506E-E6A2-4C8E-BA38-E9184C3A345BQ38123937-6F5BFF3A-80FA-40C3-A3DA-B2202672B56CQ38252639-E8C40DBE-FDA9-451D-944D-F61454A0B8BBQ38806558-7253A4EB-31F9-487C-A2B0-4018EFF2B365Q38946939-1CAF8FF5-45D1-41B0-A201-3DAF9A3C4BCAQ39094628-70037B5B-B867-4CCB-B185-29A4BB73C426Q41595324-080B71C4-E6BA-4E75-828C-BFDEFDDCC9B8Q41984765-D6A26A8E-8A87-4569-BBF9-7BA1E0E41103Q42019805-29133125-3D31-4A94-AE49-DF81BA36CFB2Q42059898-B45E6A94-D3AA-4DF4-BF2B-33EE80AE7360Q47102683-A9EF04C8-8B3E-4C18-BFC2-365BC256EF6EQ57131555-C6109DB8-5285-4000-A62D-6F63F26E5B34Q58583890-93F32647-BA8D-4F85-BE84-07903C27F0E1
P2860
Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@en
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@nl
type
label
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@en
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@nl
prefLabel
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@en
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@nl
P2093
P2860
P1476
Peptide nanoparticles as novel ...... respiratory syndrome vaccine.
@en
P2093
Peter Burkhard
Robert S Hodges
Scott A Jeffers
Tais A P F Pimentel
P2860
P356
10.1111/J.1747-0285.2008.00746.X
P577
2009-01-01T00:00:00Z